Expression, purification and spectral characterization of p21Waf1/Cip1

被引:3
|
作者
Shi Qiao-yun [1 ]
Zheng Yong-chen [2 ]
Ren Jin-song [1 ]
Qu Xiao-gang [1 ]
机构
[1] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Rare Earth Chem & Phys, Div Biol Inorg Chem, Changchun 130022, Peoples R China
[2] Jilin Univ, Clin Hosp 2, Dept Cent Lab, Changchun 130041, Peoples R China
基金
中国国家自然科学基金;
关键词
p21(Waf1/Cip1); PBV220; circular dichroism; tryptophan fluorescence;
D O I
10.1016/S1005-9040(08)60039-2
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
p21(Waf1/Cip1), best known as a broad-specificity inhibitor of cyclin/cyclin-dependent kinase complexes, can interact with various target proteins, and this ability relies on its structural plasticity. Therefore, studies on the structural properties of p(21) are very important to understand its structure-function relationship. However, detailed studies on its secondary structure and biophysical properties have been comparatively sparse. A human p(21) gene was cloned into the temperature expression vector pBV220 and transformed into Escherichia coli strain JM109. Recombinant protein was expressed as a non-fusion protein and purified by gel filtration and anion exchange chromatography. The purified protein was verified by Western blot and the functional activity was recognized by pull-down assay. Furthermore, circular dichroism, fluorescence spectroscopy, and fluorescence quenching methods were used to characterize the conformational properties of the purified protein. The results indicate that it was largely unstructured under the native solution conditions, and its tryptophan residues were exposed and located in a positively charged microenvironment. This study lays a good foundation for further study of p21 binding to its different partners.
引用
收藏
页码:192 / 195
页数:4
相关论文
共 50 条
  • [21] P21WAF1/CIP1 protein and tongue cancer prognosis
    Gonzalez-Moles, MA
    Ruiz-Avila, I
    Martinez, JAF
    Gil-Montoya, JA
    Esteban, F
    Gonzalez-Moles, S
    Bravo-Perez, M
    Bascones, A
    ANTICANCER RESEARCH, 2004, 24 (5B) : 3225 - 3231
  • [22] Topological analysis of p21WAF1/CIP1 expression in esophageal squamous dysplasia
    Shirakawa, Y
    Naomoto, Y
    Kimura, M
    Kawashima, R
    Yamatsuji, T
    Tamaki, T
    Hamada, M
    Haisa, M
    Tanaka, N
    CLINICAL CANCER RESEARCH, 2000, 6 (02) : 541 - 550
  • [23] Relationship between expression of p21WAF1/CIP1 radioresistance in human gliomas
    Kokunai, T
    Tamaki, N
    JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (06): : 638 - 646
  • [24] Expression of p21waf1/Cip1 in stromal fibroblasts of primary breast tumors
    Trimis, George
    Chatzistamou, Ioulia
    Politi, Katerina
    Kiaris, Hippokratis
    Papavassiliou, Athanasios G.
    HUMAN MOLECULAR GENETICS, 2008, 17 (22) : 3596 - 3600
  • [25] Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma
    De la Cueva, E.
    Garcia-Cao, I.
    Herranz, M.
    Lopez, P.
    Garcia-Palencia, P.
    Flores, J. M.
    Serrano, M.
    Fernandez-Piqueras, J.
    Martin-Caballero, J.
    ONCOGENE, 2006, 25 (29) : 4128 - 4132
  • [26] p21Waf1/Cip1 deficiency stimulates centriole overduplication
    Duensing, Anette
    Ghanem, Louis
    Steinman, Richard A.
    Liu, Ying
    Duensing, Stefan
    CELL CYCLE, 2006, 5 (24) : 2899 - 2902
  • [27] A mimic of p21WAF1/CIP1 ameliorates murine lupus
    Goulvestre, C
    Chéreau, C
    Nicco, C
    Mouthon, L
    Weill, B
    Batteux, F
    JOURNAL OF IMMUNOLOGY, 2005, 175 (10): : 6959 - 6967
  • [28] Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma
    E De la Cueva
    I García-Cao
    M Herranz
    P López
    P García-Palencia
    J M Flores
    M Serrano
    J Fernández-Piqueras
    J Martín-Caballero
    Oncogene, 2006, 25 : 4128 - 4132
  • [29] p21WAF1/CIP1与乳腺癌
    马双慰
    国外医学(生理、病理科学与临床分册), 2001, (06) : 493 - 495
  • [30] p21Waf1/Cip1 Polymorphisms and Risk of Esophageal Cancer
    Wenjun Yang
    Qi Qi
    Heng Zhang
    Wenda Xu
    Zhiqiang Chen
    Li Wang
    Yin Wang
    Xiaowei Dong
    Haiyan Jiao
    Zhenghao Huo
    Annals of Surgical Oncology, 2010, 17 : 1453 - 1458